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ABSTRACT 
Objective: Gastro-oesophageal reflux disease is thought to be a risk factor for head and neck 
malignancies. Bile acids are one of the principle components of gastric refluxate and have 
previously been implicated in the development of oesophageal and bowel malignancies. There is 
clear evidence that bile acids reflux into the laryngopharynx. Despite this, the carcinogenic 
properties of bile acids in this area are yet to be fully identified. We therefore investigated the 
potential role of bile acids in pharyngeal malignancy, through the highly conserved process of 
epithelial-mesenchymal transition (EMT). EMT occurs in invasion and metastasis and is a 
central process in the development of epithelial carcinoma.  
 
Design: Translational research study 
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Methods: Human hypopharyngeal squamous carcinoma FaDu cells were challenged with 
primary (cholic or chenodeoxycholic) and secondary (deoxycholic or lithocholic) bile acids. 
EMT relevant proteins TGF-β1 and MMP-9 were measured in the cell culture supernates at 48-
hours via ELISA. Cell viability was confirmed >95% via CellTiter-Blue assay.  
Results: Significantly greater concentrations of TGF-β1 were measured in the culture supernates 
of cells treated with cholic acid, deoxycholic acid, chenodeoxycholic acid.  MMP-9 levels were 
increased in deoxycholic acid and lithocolic acid stimulations when compared to control 
(p<0.05). 
Conclusion: This is the first demonstration that bile acids induce TGF-β1 and MMP-9 in 
pharyngeal cells. TGF-β1 is considered a master switch for EMT while MMP-9 is a part of the 
EMT proteome which degrades basement membranes. This implies a potential role for bile acids 
in pharyngeal carcinogenesis through the mechanism of EMT and suggests potential novel 
therapeutic targets. 
 
INTRODUCTION 
Globally there are 600,000 new cases and 300,000 deaths from head and neck cancer (HNC) 
worldwide per year1. Despite improvements in treatment modalities, HNC still carries a poor 
prognosis and has a substantial impact on quality of life2. While tobacco smoking, alcohol and 
high-risk papilloma viruses are well recognized etiologic agents, gastro-oesophageal reflux 
disease (GORD) is being increasingly implicated as a risk factor in the development of HNC, 
particularly pharyngeal and laryngeal subsites3,4. 
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GORD is highly prevalent in the general population5. There is clear evidence that duodeno-
gastric contents are refluxed beyond the esophagus in so-called extra-oesophageal or 
laryngopharyngeal reflux (LPR) episodes6. Gastric refluxate contains gastric acid, pepsin and 
bile acids. Evidence of all three components has been found in upper airway samples7-9. 
 
Increasing evidence is emerging for the role of pepsin and acidic environments in inducing 
laryngopharyngeal carcinogenesis10-14. The carcinogenic properties of bile acids in this area are 
yet to be fully identified. This is despite the potent carcinogenic properties of bile acids identified 
in other digestive subsites, such as gastro-oesophageal15,16 and colonic17,18. 
 
We therefore investigated the impact of bile acids on a head and neck squamous cell line, 
specifically the highly conserved process of epithelial-mesenchymal transition (EMT). EMT is a 
central process in the development of carcinoma and contributes to cancer invasion and 
metastasis19. Transforming Growth Factor beta 1 (TGF-β1) is the recognized ‘master switch’ that 
promotes EMT while Matrix Metalloproteinase 9 (MMP-9) is a part of the EMT proteome which 
degrades basement membranes. Both TGF-β1 and MMP-9 have been shown to play an important 
role in EMT in HNC20 21.  
 
MATERIALS AND METHODS  
Cell culture  
Human hypopharyngeal squamous cell carcinoma FaDu cells (ATCC, USA) were cultured on 
collagen coated flasks in Eagle’s Minimum Essential Medium supplemented with fetal calf 
serum 10%, non-essential amino acids 0.1mM, Penicillin/Streptomycin 100U/100μgmL-1 and L-
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Glutamine 2mM (Sigma, USA), incubated at 37°C in a 5% CO2 incubator. Medium was changed 
every 2 – 3 days. Upon near confluence, cells were trypsinised (Sigma, USA), diluted in equal 
volume medium, centrifuged at 200G for 7 minutes and seeded in a new container.  
 
Bile acid preparation and challenge 
The four predominant bile acids in the human digestive tract are Cholic acid (CA), Lithocholic 
acid (LA), Deoxycholic acid (DA), and Chenodeoxycholic acid (CDA). Each stock bile acid 
(Sigma, USA) was prepared in methanol. Controls contained methanol alone. Bile acids or 
methanol controls were diluted in resting medium for all experiments. Resting medium 
comprised standard culture media excluding fetal calf serum. Cells were placed in resting 
medium for a minimum of 3 hours prior to bile acid challenges in order to promote the resting 
phase of the growth cycle.  
 
Enzyme-linked immunosorbent assays (ELISAs) 
After 48 hours challenge cell culture supernates were collected and stored in a -80°C freezer 
until use. Human TGF-β1 and Human MMP-9 DuoSet ELISA kits (R&D, USA) were used 
according to the manufacturers instructions. Samples were diluted to optimum concentrations 
and absorbance measured at 450nm with a plate reader (Tecan M200) and compared against a 
known concentration standard curve to calculate unknown concentrations. 
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CellTiter-Blue Viability Assay  
Cell viability was assessed using CellTiter-Blue viability assay (Promega, USA). After the 48-
hour challenge period, the supernate was removed and a CellTiter-Blue reagent was added to the 
cells for 3 hours. No-cell controls were prepared in triplicate to determine the background 
absorbance. Dead cell controls were also set up in triplicate by adding 100% methanol to cells. 
Live unchallenged cell controls were also set up in triplicate. Fluorescence excitation and 
emission ratio was measured at 560nm and 590nm respectively. Percentage viability was 
calculated from fluorescence of challenged cells against controls. 
 
Statistical Analysis  
Data from each experiment compromised 4 biological replicates, each with 2 technical replicates. 
Analysis was performed on Prism 5 (GraphPad, CA, USA) using Mann-Whitney U tests. 
Comparison was made between each experimental condition and control results. Data was 
expressed as mean ± the standard error of the mean (SEM). Significance was taken as p<0.05. 
 
RESULTS 
We demonstrated a significant (p<0.05, n=4) increase in the expression of TGF-β1 (via ELISA 
of cell culture supernates) with exposure to concentrations of CDA 100µM, CA 600µM and DA 
100µM, 75µM compared to control samples. LA at concentrations up to 20µM did not produce a 
significant increase in TGF-β1 levels  (figure 1). MMP-9 ELISA of cell supernate showed a 
significant (p<0.05, n=4) increase in MMP-9 in challenged human FaDu cells compared to 
controls at concentrations of DA 100μM and LA 100μM. CA at concentrations up to 600µM  
and CDA at concentrations up to 100µM produced no significant increase in MMP-9 
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concentrations compared to controls (figure 2).  Cell viability was confirmed at >95% in all 
experimental conditions by CellTiter-blue viability assay. 
 
DISCUSSION 
Synopsis of key findings 
We have demonstrated for the first time a potential link between bile acids and up regulation of 
proteins implicated in EMT and cancer. We investigated proteins associated with EMT that are 
recognized to have a substantial role in the development of epithelial tumors and are of 
significant relevance in HNC19-21. TGF-β1 is considered the ‘master switch’ for EMT and can 
induce changes in epithelial architecture and phenotype accompanied by an EMT signature 
proteome, ultimately resulting in the epithelial cells transitioning to a mesenchymal phenotype21. 
MMP-9 is a type IV collagenase and is a potent basement membrane degrading enzyme which 
has been closely tied to epithelial cells being able to invade into local structures21.  
 
Significantly greater concentrations of TGF-β1 were measured in the culture supernates of cells 
treated with cholic acid (CA), deoxycholic acid (DA), chenodeoxycholic acid (CDA), and of 
MMP-9 in the cell culture supernates of cells challenged with deoxycholic acid (DA) and 
lithocholic acid (LA), when compared to controls (p<0.05). We used concentrations of the 
differing bile acids up to the maximal concentration that did not induce high cell death based on 
our optimization work. CellTiter-blue viability assay confirmed >95% cell viability in all 
conditions, hence release of these EMT markers was from cell expression and not cell death. The 
variable role of the different bile acids on EMT markers was a surprising finding. TGF-β1 is 
considered an earlier EMT marker and may promote MMP-9 production22. Therefore as DA was 
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the most potent TGF-β1 stimulator it could be hypothesized that this lead to downstream 
production of MMP-9. The finding that LA only produced significant increased amounts of 
MMP-9, and not TGF-β1, requires further investigation of alternative EMT pathways. E-
cadherin and Fibronectin are then next two most relevant EMT markers and future study of their 
expression would be of benefit. 
 
Strengths and weaknesses of the study 
A limitation of this study is absence of evidence quantifying the concentrations of each bile acid 
in the laryngopharynx during or after reflux events. Therefore extrapolation of these current 
results to the in vivo environment is difficult. In humans, CA, CDA and DA are predominantly 
found in the digestive tract, with only small amounts of LA present (<10%)23. The total 
concentrations of bile acids in gastric juice, derived from the stomach, are quoted as between 10 
– 10,000μM24. We used a range of between 15 - 600μM for each individual bile acid, so are well 
within the physiological range expected in gastric refluxate. However, further investigation of 
the dose response relationship over a broader range of concentrations would be of interest in 
future studies. The use of a cell line carries numerous limitations and further studies in primary 
cells is now required. The FaDu hypopharyngeal squamous cell line is however a well 
established and characterized cell line in reflux and head and neck cancer research14. 
 
Comparisons with other studies 
There is a large body of evidence demonstrating an association between GERD and oesophageal 
malignancy25. The relationship between GERD and head and neck malignancies is less clearly 
established. A recent meta-analysis by Zhang et al3 summarized the conflicting findings of recent 
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population based studies. They highlighted the difficulty in demonstrating an association due to 
the substantial confounding smoking and alcohol history in the cancer groups.  
Several in vitro studies have demonstrated a potential role of reflux constituents, pepsin and acid, 
in prompting laryngopharyngeal carcinogenesis10-14. However, Galli et al26 in a series of 40 
achlorhydric gastrectomised patients demonstrated that 15% developed premalignant or 
malignant laryngeal tumours compared to 2.5% in a control group of dyspeptic patients, 
indicating a potentially substantial role of bile acids in laryngopharyngeal carcinogenesis. 
Further to this there is an increasing body of in vitro evidence demonstrating a potential link 
between bile acids and other digestive subsites malignancies, such as gastro-oesophageal15,16 and 
colonic17,18. 
We could identify only two other studies, which investigated cellular mechanistic relationships 
between bile acids and head and neck squamous cells. Sung et al27 demonstrated increased 
expresssion of Cyclo-Oxygenase-2 (COX-2) by pharyngeal cells after challenge with CDA. In a 
more recent study, Sasaki et al28 demonstrated increased expression of nuclear factor-kappaB 
(NF-κB) by hypopharyngeal cells after challenge with a cocktail of bile acids. Our study has 
however, for the first time, been able to demonstrate differing potencies and mechanistic 
relationships between each of the four main human bile acids on EMT pathways in head and 
neck squamous cells.  
 
Clinical applicability of the study 
This is a preliminary in vitro study, which demonstrates a potentially important link between bile 
acids found in duodeno-gastric refluxate and HNC.  
 
A
cc
ep
te
d 
A
rt
ic
le
This article is protected by copyright. All rights reserved. 
The importance in identifying gastro-duodenal refluxate as a potential co-factor in HNC is the 
potential for preventative interventions, such as counteracting reflux in individuals at high-risk of 
HNC. The other essential consideration of bile acids as a specific causative agent in HNC is the 
need to move away from acid neutralization agents alone. Agents such as proton pump inhibitors 
do not reduce biliary secretions or impede bile acid function. Other agents such as alginates may 
have an effect in physically blocking biliary reflux into the laryngopharynx.  
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Legends to Illustrations 
Figure 1 – Elevation of TGF-β1 in cell culture supernates after 48hr challenge with bile 
acids: FaDu cells were challenged with bile acids, after 48 hours TGF-β1 concentrations were 
measured in the cell culture supernates (n=4), *p<0.05. CellTiter-Blue viability assay showed 
>95% cell viability in each experimental condition. 
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